The CapitalBiotech Eye Segment Analysis Device combines traditional Chinese medicine (TCM) eye assessment concepts with analysis of bulbar conjunctival microcirculation. Using AI-assisted image analysis, clinical data, and shadowless optical imaging, the system captures and analyzes high-definition eye images to support TCM syndrome assessment and health-risk evaluation, and to generate personalized health management information.